Clinical Trials
36 trialsProfiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
National Institutes of Health Clinical Center (CC)
X-SMILE
University of Zurich
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
RAVI Registry
Terumo Medical Corporation
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
Shanghai Changzheng Hospital
MOSES
University Hospital, Bordeaux
JPET2Clinic
Jagiellonian University
Impact of COVID-19 on GU Disease
Icahn School of Medicine at Mount Sinai
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
Alanya Alaaddin Keykubat University
CARE
Profound Medical Inc.
Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia
Universität des Saarlandes
PROMIC
Turku University Hospital
Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia
Bezmialem Vakif University
Protein Kinase A in Prostate Cancer Tissue.
Ziv Hospital
PSA
University of Baghdad
Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder
Ankara Training and Research Hospital
Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
Wake Forest University Health Sciences
Application of DWI in Diagnosis of Prostate Cancer
Peking University Third Hospital
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
National Cheng-Kung University Hospital
VPAC
Intermountain Health Care, Inc.
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship
Changhai Hospital
CANARI
Rennes University Hospital
BHOS
CMX Research
ARI103094-Follow-Up Study for REDUCE Study Subjects
GlaxoSmithKline
Economic Analyses of the REDUCE Trial
GlaxoSmithKline
RESPECT
GlaxoSmithKline
DiRECT
University of Virginia
EDtoPC
Kuang Tien General Hospital
WEUSKOP5723: Prostate Cancer Study
GlaxoSmithKline
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
St. Luke's Medical Center, Philippines
2013 Annual National Digital Rectal Exam (DRE) Day Study
St. Luke's Medical Center, Philippines
PMI
Artann Laboratories
Duke Urology Database and Specimen Bank
Duke University
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
Seoul National University Hospital
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
ProteoSys AG